Cytogenetic and comorbidity profile of Down syndrome in Mansoura University Children's Hospital, Egypt

Abdel-Hady El-Gilany, Sohier Yahia, Mohamed Shoker, Faeza El-Dahtory, Abdel-Hady El-Gilany, Sohier Yahia, Mohamed Shoker, Faeza El-Dahtory

Abstract

Background: Down syndrome (DS) is the most common chromosomal disorder. It has three chromosomal patterns.

Aim: To determine the cytogenetic and comorbidity profiles of DS in the Genetic Unit of Mansoura University Children's Hospital, Mansoura, Egypt.

Materials and methods: A retrospective analysis was performed on the case records of 712 cytogenetically diagnosed cases of DS at the Genetic Unit of Mansoura University Children's Hospital, Egypt, during a 10-year period.

Results: About 19% of the cases had one or more cardiac anomalies and about 8% were hypothyroid. Nondisjunction was the most common type of abnormality, followed by translocation and lastly mosaic: 96.1, 3.1, and 0.8%, respectively. Hypothyroidism was significantly more common in translocation and mosaic karyotypes than in the nondisjunction karyotypes. First and second birth orders were significantly higher in the translocation and mosaic groups than in the nondisjunction group. Mothers are significantly older at the index pregnancy in the nondisjunction group than in the other two groups. We compared our findings with those of previous studies.

Conclusion: Knowing karyotype of DS will help in genetic counseling of the parents. Wide-scale national community-based survey with DS registry could help in estimating the size of the problem.

Keywords: Down syndrome; karyotypes; mosaic; nondisjunction; translocation.

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. El-Sobky E, Elsayed S. Down syndrome in Egypt. Egypt J Med Hum Genet. 2004;5:67–78.
    1. Murthy SK, Malhotra AK, Mani S, Shara ME, Al-Rowaished EE, Naveed S, et al. Incidence of Down Syndrome in Dubai, UAE. Med Princ Pract. 2007;16:25–8.
    1. Gardner RJ, Sutherland GR. Chromosome abnormalities and genetic counseling. 3rd ed. Oxford: Oxford University Press; 2004. pp. 243–58.
    1. Abdel-Fattah S. Congenital anomalies prevalent among Mongols. Egypt J Paediatr. 1991;8:369.
    1. Warburton D, Dallaire L, Thangavelu M, Ross L, Levin B, Kline J. Trisomy recurrence: A reconsideration based on North American data. Am J Hum Genet. 2004;75:95–100.
    1. Morton NE, Jacobs PA, Hassold T, Wu D. Maternal age in trisomy. Ann Hum Genet. 1988;52(pt 3):227–35.
    1. Lamb NE, Yu K, Shaffer J, Feingold E, Sherman SL. Association between maternal age and meiotic recombination for trisomy 21. Am J Hum Gent. 2005;76:91–9.
    1. Hassold T, Sherman S. Trisomy recurrence: A reconsideration based on North American data. Am J Hum Genet. 2004;57:95–100.
    1. Newberger DS. Down Syndrome: Prenatal risk assessment and diagnosis. (837-8).Am Fam Physician. 2000;62:825–832.
    1. Lamb NE, Freeman SB, Savage-Austin A, Pettay D, Taft L, Hersey J, et al. Susceptible chiasmate configuration of chromosome 21 predispose to non-disjunction in both maternal MI and MII. Nat Genet. 1996;14:400–5.
    1. Verma IC, Mathew S, Elango R, Shukla A. Cytogenentic studies in Down syndrome. Indian Pediatr. 1991;28:991–6.
    1. Mutton D, Alberman E, Hook EB. Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989to 1993. National Down Syndrome Cytogenetic Registerand the Association of clinical cytogeneticists. J Med Genet. 1996;33:387–94.
    1. Mokhtar MM, Abd el-Aziz AM, Nazmy NA, Mahrous HS. Cytogenetic profile of Down syndrome in Alexandria, Egypt. East Mediterr Health J. 2003;9:37–44.
    1. Kava MP, Tullu MS, Muranjan MN, Girisha KM. Down syndrome: Clinical profile from India. Arch Med Res. 2004;35:31–5.
    1. Jyothy A, Kumar KS, Rao GN, Rao VB, Swarna M, Devi BU, et al. Cytogenetic studies of 1001 Down syndrome cases from Andhra Pradesh, India. Indian J Med Res. 2000;111:133–7.
    1. Ahmed I, Ghafoor T, Samore NA, Chattha MN. Down syndrome: Clinical and cytogenetic analysis. J Coll Physicians Surg Pak. 2005;15:120–32.
    1. James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, et al. Abnormal folate metabolism and mutation in the methyl-tetrahydrofolate reductase gene may be maternal risk factor for Down syndrome. Am J Clin Nutr. 1999;70:495–501.
    1. Gibson PA, Newton RW, Selby K, Price DA, Leyland K, Addison GM. Longitudinal study of thyroid function in Down's syndrome in the first two decades. Arch Dis Child. 2005;90:475–578.
    1. Rooney DE, Czepulkowski BH. Human Chromosome Preparation, Essential Techniques Series, D. Rickwood, Department of Biological and Chemical sciences, University of Essex, Wivenhoe Park, Colchester. UK: University Press; 1997. pp. 37–8.
    1. Wahab AA, Bener A, Sandridge AL, Hoffmann GF. The pattern of Down syndrome among children in Qatar: A population-based study. Birth Defects Res A Clin Mol Teratol. 2006;76:609–12.
    1. Al-Awadi SA, Farag TI, Teebi AS, Naguib KK, El-Khalifa MY, Marafie MJ, et al. Cytogenetic profile of Down syndrome in Kuwait: A decade of experience. J Egypt Public Health Assoc. 1991;16(suppl):259–69.
    1. Jaouad IC, Cherkaoui Deqaqi S, Sbiti A, Natiq A, Elkerch F, Sefiani A. Cytogenetic and epidemiological profiles of Down syndrome in a Moroccon population: A report of 852 cases. Singapore Med J. 2010;51:133–6.
    1. Shariaty M, Azimi C. Brisbane, Australia: Presented at 11th International Congress of Human Genetics; 2006. Aug 6-10, Cytogenetics epidemiology of Down syndrome in Iran: A forty years study.
    1. Alp MN, Oral D, Budak T. Cytogenetic analysis of 584 cases with clinical diagnosis of Down syndrome (Article in Turkish) Dicle Tip Dergisi. 2007;34:283–9.
    1. Thomas IM, Rajangam S, Hegde S. Cytogenetic investigations in Down syndrome patients and their parents. Indian J Med Res. 1992;96:366–71.
    1. Sheth F, Rao S, Desai M, Vin J, Sheth J. Cytogenetic analysis of Down syndrome in Gujarat. Indian Pediatr. 2007;44:774–7.
    1. Kothare S, Shetty N, Dave U. Maternal age and chromosomal profile in 160 Down syndrome cases- experience of a tertiary genetic center from India. Int J Hum Genet. 2002;2:49–53.
    1. Chandra N, Cyril C, Lakshminarayana P, Nallasivam P, Ramesh A, Gonipath PM, et al. Cytogenetic evaluation of Down syndrome: A review of 1020 referral cases. Int J Hum Genetics. 2010;10:87–93.
    1. Satish KR. Down syndrome, A clinical biological and genetic profile. [Last accessed on 2010 Aug 1]. Available at: .
    1. Mandava S, Koppaka N, Bhatia D, Das BR. Cytogenetic analysis of 1572 cases of Down syndrome: A report of double aneuploidy and novel findings 47,XY,t(14;21) (q13;q22.3)mat,+21 and 45,XX,t(14;21) in an Indian population. Genetic Test Mol Biomarkers. 2010;14(4):499–504.
    1. Malini SS, Ramachandra NB. Possible risk factors for Down syndrome and sex chromosomal aneuploidy in Mysore, South India. Indian J Hum Genet. 2007;13:102–8.
    1. Jayalakshama, Margaret M, Amudha S, Tilak P, Devi R, Rajangam S. Cytogenetic analysis in Down syndrome. Int J Hum Genet. 2010;10:95–9.
    1. Murthy SK, Murthy DS, Shah VC, Desai AB. Down syndrome in Ahmedabad: karyotype analysis in 60 cases. Indian J Pediatr. 1987;54:723–7.
    1. Azman BZ, Ankathil R, Siti Mariam I, Suhaida MA, Norhashimah M, Tarmizi AB, et al. Cytogenetic and clinical profile of Down syndrome in Northeast Malaysia. Singapore Med J. 2007;48:550–4.
    1. Biselli J, Goloni-Bertollo E, Ruiz M, Pavarino-Bertelli E. Cytogenetic profile of Down syndrome cases seen by a general genetics outpatient service in Brazil. Down Syndrome Res and Practice. 2009;12:EJ850568.
    1. English CJ, Davison EV, Bhate MS, Barrett L. Chromosome studies of males in an institution for the mentally handicapped. J Med Genet. 1989;26:379–81.
    1. Mutton D, Alberman E, Hook EB. Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989 to 1993.National Down syndrome cytogenentic rwgister and the association of clinical cytogeneticists. J Med Genet. 1996;33:387–94.
    1. Stoll C, Alembik Y, Dott B, Roth MP. Epidemiology of Down syndrome in 118265 consecutive births. Am J Med Genet Suppl. 1990;7:79–83.
    1. Mulcahy MT. Down's syndrome in Western Australia: Cytogenetics and incidence. Hum Genet. 1979;48:67–72.
    1. Kovaleva NV. Sex ration in Down syndrome (Article in Russian) Tsitol Genet. 2002;36:54–69.
    1. Chan A, McCaul KA, Keane RJ, Haan EA. Effect of parity, gravidity, previous miscarriage and age on the risk of Down syndrome: Population study. BMJ. 1998;317:923–4.
    1. Schimmel MS, Zadka P. Increased parity and risk of trisomy 21: Review of 317,110 live births. BMJ. 1997;314:720.
    1. Clementi M, Bianca S, Benedicenti F, Tenconi R. Down syndrome and parity. Community Genet. 1999;2:18–22.
    1. Kallan K. Parity and Down syndrome. Am J Med Genet. 1997;70:196–201.
    1. Doria-Rose VP, Kim HS, Augustine ET, Edwards KL. Parity and the risk of Down's syndrome. Am J Epidemiol. 2003;158:503–8.
    1. Cutler AT, Benezra-Obeiter R, Brink SJ. Thyroid function in young children with Down syndrome. Am J Dis Child. 1986;140:479–83.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel